David Karow was recently named CEO of Human Longevity, which comes after Craig Venter announced his retirement from the role on May 24.
FINANCE: Ansun Led the Way With $85M Series A
It’s another record-setting quarter. Investment in San Diego-based life sciences companies hit a record high $427.5 million in the second quarter of 2018, according to a July CBRE Group Inc. report. This figure beat the preceding quarter’s $417.9 million in investment, which was a record at the time, and represents a 32 percent year-over-year jump.
On average, stocks of public life sciences companies in San Diego gained 12 percent during the second quarter, lifted in large part by a diabetes pump maker.
Life sciences veteran Kieran Gallahue was named to Arena Pharmaceuticals’ board of directors.
San Diego-based Synteract has acquired Cu-Tech, and has established a center for dermatology development, with the aim of being a big player in dermatology clinical trials.
San Diego-based ResMed and Verily, a subsidiary of Google parent company Alphabet, have formed a new venture to develop software for identifying, diagnosing and treating sleep apnea and other breathing disorders.
BrainLeap cofounders, UCSD neuroscientists, aim to turn research discoveries into effective treatments.
San Diego-based Crinetics Pharmaceuticals laid out terms for a planned initial public offering in paperwork filed July 9.
WORKFORCE: Sector Stresses Opportunities to Job Candidates, Students
It’s an employment intersection that’s only growing more pronounced.
San Diego staffing company AMN Healthcare has brought Mark Hagan on board as chief information officer.
FITNESS: From Informal Start, It Moves to Franchising, Studios, and Digital Programs
For Lisa Druxman, chief founding mom of Fit4mom (formerly known as “Stroller Strides”), the San Diego-based company which provides fitness for every stage of motherhood, launching the business 17 years ago came from pure necessity.
San Diego-based Beacon Discovery has added square footage and employees following partnership deals.
San Diego’s SGI-DNA, a spinout of Synthetic Genomics, has named life sciences veteran Todd Nelson as CEO.